Lumida
/HALO
⌘K
Halozyme Therapeutics Inc

Halozyme Therapeutics Inc

HALO
$107.20USD+0.19%+0.20 today

MARKET CAP

12.2B

P/E (TTM)

20.0x

FWD P/E

10.6x

DAY RANGE

$106 – $108

52W RANGE

$61
$111

AI Summary

Stalk
StalkMedium

HALO remains in a constructive Stage 2 uptrend above rising EMAs but shows a Bullish Exhaustion signal and overbought readings. Price is currently pulling back into the 9- and 20-day EMAs, offering a potential re-entry zone. The medium-term bias stays bullish, yet short-term timing is unfavorable, so execution should be deferred until a clear hold or rejection off the EMA zone.

  • Total revenue up 48% YoY to $481 M, driven by 50% royalty growth.
  • FY26 revenue guide raised 31–37% to $1.835–1.91 B, reflecting robust outlook.
  • Weak book-to-price ratio indicates potential valuation headwinds.
Full analysis →

Buying

8

institutions

Selling

8

institutions

New Positions

2

this quarter

Filing Period

Q1 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
BI

Blackrock, Inc.

Q2 2026

BUY13.27 M1.04 B+6.04 K+21.2%0.02%
JH

Janus Henderson Group Plc

Q1 2026

BUY2.47 M159.48 M+1.60 M+174.3%0.04%
AC

Aqr Capital Management LLC

Q2 2026

SELL785.56 K61.49 M+-230.87 K-5.1%0.02%
JC

Jpmorgan Chase & Co

Q2 2026

SELL485.92 K37.93 M+-147.81 K-3.7%0.00%
RT

Renaissance Technologies LLC

Q2 2026

SELL479.61 K37.54 M+-252.20 K-20.6%0.05%
BA

Bridgewater Associates, LP

Q2 2026

SELL463.15 K36.25 M+-48.28 K+9.7%0.15%
FA

Fisher Asset Management, LLC

Q2 2026

SELL427.71 K33.48 M+-16.98 K+16.5%0.01%
CA

Citadel Advisors LLC

Q2 2026

BUY422.49 K33.07 M+140.64 K+81.5%0.00%
CP

California Public Employees Retirement System

Q2 2026

BUY282.67 K22.12 M+21.71 K+31.2%0.01%
MG

Man Group Plc

Q2 2026

BUY158.77 K12.43 M+17.28 K+35.9%0.02%
WP

Woodline Partners LP

Q2 2026

BUYNEW104.16 K8.15 M+104.16 K+0.0%0.03%
HS

Hussman Strategic Advisors, Inc.

Q2 2026

SELL42.00 K3.29 M+-10.50 K-3.1%0.76%
MM

Millennium Management LLC

Q2 2026

SELL19.86 K1.55 M+-451.43 K-94.9%0.00%
RC

Rockefeller Capital Management L.P.

Q2 2026

BUY8.11 K634.85 K+489.00+28.9%0.00%
BH

Brevan Howard Capital Management LP

Q2 2026

BUYNEW4.53 K354.41 K+4.53 K+0.0%0.00%
VI

Voloridge Investment Management, LLC

Q2 2026

SELL0.000.00+-310.51 K-100.0%0.00%